Legis Daily

To direct the Secretary of Health and Human Services to issue guidance with respect to three-dimensional human tissue models, and for other purposes.

USA115th CongressHR-2558| House 
| Updated: 5/26/2017
Chris Collins

Chris Collins

Republican Representative

New York

Cosponsors (2)
Scott H. Peters (Democratic)Billy Long (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Patient Safety and Toxicology Modernization Act of 2017 This bill requires the Food and Drug Administration to issue and periodically update guidance on: (1) novel tools for testing the toxicology and efficacy of medications, and (2) three-dimensional human tissue models.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 19, 2017
Introduced in House
May 19, 2017
Referred to the House Committee on Energy and Commerce.
May 26, 2017
Referred to the Subcommittee on Health.
  • May 19, 2017
    Introduced in House


  • May 19, 2017
    Referred to the House Committee on Energy and Commerce.


  • May 26, 2017
    Referred to the Subcommittee on Health.

Health

Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyMedical researchMedical tests and diagnostic methods

To direct the Secretary of Health and Human Services to issue guidance with respect to three-dimensional human tissue models, and for other purposes.

USA115th CongressHR-2558| House 
| Updated: 5/26/2017
Patient Safety and Toxicology Modernization Act of 2017 This bill requires the Food and Drug Administration to issue and periodically update guidance on: (1) novel tools for testing the toxicology and efficacy of medications, and (2) three-dimensional human tissue models.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 19, 2017
Introduced in House
May 19, 2017
Referred to the House Committee on Energy and Commerce.
May 26, 2017
Referred to the Subcommittee on Health.
  • May 19, 2017
    Introduced in House


  • May 19, 2017
    Referred to the House Committee on Energy and Commerce.


  • May 26, 2017
    Referred to the Subcommittee on Health.
Chris Collins

Chris Collins

Republican Representative

New York

Cosponsors (2)
Scott H. Peters (Democratic)Billy Long (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyMedical researchMedical tests and diagnostic methods